Sesen Bio Stock Price - SESN

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Sesen Bio Inc SESN NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.0176 -1.61% 1.0724 1.10 1.03 1.10 1.09 11:12:04
Bid Price Ask Price Spread Spread % News
1.07 1.08 0.01 0.93% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
897 735,607 $ 1.07 $ 789,292 1,718,418 0.6609 - 2.64
Last Trade Time Type Quantity Stock Price Currency
11:12:04 1,000 $ 1.0724 USD

Sesen Bio Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 112.26M 104.68M $ -33.69M -0.52 - 103.58M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 1.00%

more financials information »

Sesen Bio News

Loading Messages....

Latest SESN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SESN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.,761,058-0.1076-9.12%
1 Month1.141.381.031.181,450,741-0.0676-5.93%
3 Months1.091.551.031.211,254,903-0.0176-1.61%
6 Months1.911.951.021.291,457,345-0.8376-43.85%
1 Year1.532.640.66091.351,892,358-0.4576-29.91%
3 Years2.143.500.62011.671,482,158-1.07-49.89%
5 Years11.5113.790.25111.981,346,562-10.44-90.68%

Sesen Bio Description

Sesen Bio Inc is a late-stage clinical company engaged in next-generation antibody-drug conjugate therapies for the treatment of cancer based on the company's Targeted Protein Therapeutics platform. The company's lead program, Vicinium, also known as VB4-845, is currently in a Phase 3 registration trial, the VISTA Trial, for the treatment of high-grade non-muscle invasive bladder cancer.

Your Recent History
Sesen Bio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.